Skip to main content
Contact Us
Sign Up
Subscriber Sign In
English
日本語
navigation
Search
What We Do
Vantage
News
Analysis
Policy & Pricing
Data Insights
Events
Medtech
Therapy Areas
About Vantage
Editorial team
Products & Services
Consensus Forecasts
Pharma
EvaluatePharma
EvaluatePharma Vision
Custom Solutions
How We Can Help You
Pharma and Biotech
Medtech
Financial Services
Management Consultancies
Service Providers
Client Success
Customer Testimonials
Thought Leadership
English
日本語
About Us
Media Centre
Press Releases
Media Coverage
Executive Team
Vision & History
Careers
Current Vacancies
Contact Us
Sign Up for Vantage
Subscriber Sign In
Search
Open configuration options
Search
Vantage
News
Snippets
Deals
Trial results
Patents and litigation
Corporate strategy
Analysis
Interviews
Spotlight
Vantage points
Vantage views
Policy & Pricing
Policy & Regulation
Pricing
Data Insights
M&A
IPO
NME approvals
Quarterly shareprice performance
Venture financing
Vantage data points
Other data
Events
Company events
Conferences
Upcoming events
Medtech
Therapy Areas
About
Editorial team
University of Michigan
June 27, 2017
Vantage Point – CAR-T value calculation in the firing line
June 04, 2017
Asco – Lynparza gets Parp edge in breast cancer
November 01, 2016
Vantage Point – Medtech needs to up its cybersecurity game
August 12, 2015
Vantage point – US insurer mergers shrink drug buyer pool
April 18, 2012
Event - Late entrant Protalix hoping to finally cross the Gaucher’s finishing line
June 07, 2011
Vantage Point - Swelling TKI field prompts calls for new approaches in kidney cancer
August 31, 2010
ESC - Eisai and Relypsa contribute good looking mid-stage candidates
September 14, 2009
Vantage Point - Daxas finds fans among doctors at ERS
June 02, 2008
ASCO - ImClone falls as investors not wild about Erbitux biomarker
We use cookies on this website. By using this site, you agree that we may store and access cookies on your device.
Find out more.
OK
Kickstarting ideas
Independent, data-driven daily news and analysis on pharma, biotech and medtech.
Sign up
Latest Reports
December 17, 2019
Vantage 2020 Preview
July 31, 2019
Vantage Pharma, Biotech & Medtech Half-Year Review 2019
Editor's Picks
January 09, 2020
What makes a great year for takeovers?
January 07, 2020
Surprise! There’s a tumour in which Keytruda doesn’t work
December 19, 2019
Gene therapy clinical holds take centre stage
December 20, 2019
Plenty of choice remains for buyers of gene therapy
October 14, 2019
Uncovering biopharma’s hidden treasures
